US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 0.1529
  • -0.0061-3.84%
Trading Apr 29 11:12 ET
2.39MMarket Cap-186P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-217.24%-1.1M
32.73%-1.23M
85.98%-215K
-44.82%-6.15M
-74.98%-2.44M
-6.75%-348K
-40.34%-1.83M
-25.35%-1.53M
-25.61%-4.25M
5.74%-1.4M
Net income from continuing operations
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
-917.00%-1.02M
19.22%-887K
-28.76%-5.09M
19.56%-2.94M
Operating gains losses
----
----
----
99.86%-1K
----
----
----
----
6.10%-723K
--150K
Depreciation and amortization
40.63%45K
60.71%45K
45.16%45K
-32.80%125K
-30.61%34K
-13.51%32K
-46.15%28K
-35.42%31K
-18.06%186K
22.50%49K
Deferred tax
----
----
325.00%90K
95.54%-37K
--207K
----
----
---40K
---829K
----
Other non cash items
----
----
----
-22.42%173K
----
----
----
----
5,475.00%223K
----
Change In working capital
-132.99%-515K
116.90%168K
204.70%891K
-159.53%-1.86M
-148.23%-1.58M
131.26%1.56M
-69.05%-994K
-266.81%-851K
126.23%3.13M
20.04%3.28M
-Change in receivables
-306.23%-596K
311.49%184K
361.64%191K
-96.85%62K
-103.30%-67K
-46.18%289K
81.99%-87K
34.82%-73K
-24.42%1.97M
-5.36%2.03M
-Change in inventory
-274.04%-496K
163.60%173K
231.43%230K
--0
-39.10%162K
166.90%285K
-494.20%-272K
-1,844.44%-175K
-53.85%-100K
-21.30%266K
-Change in prepaid assets
185.14%499K
-72.30%131K
-10.53%-84K
33.48%-306K
-52.96%-878K
-55.92%175K
785.51%473K
64.49%-76K
-9,100.00%-460K
-240.69%-574K
-Change in payables and accrued expense
-85.13%101K
52.88%-499K
-18.35%516K
-138.66%-341K
-189.71%-593K
534.58%679K
-2,202.17%-1.06M
295.00%632K
182.66%882K
650.83%661K
-Change in other current assets
-72.60%20K
--0
154.84%79K
----
----
1.39%73K
-211.11%-10K
-53.73%31K
----
----
-Change in other current liabilities
71.83%-20K
--0
15.96%-79K
22.07%-173K
-2.60%-79K
0.00%-71K
987.50%71K
-42.42%-94K
-3.26%-222K
-160.16%-77K
-Change in other working capital
-117.56%-23K
262.73%179K
103.47%38K
-204.34%-1.11M
-102.77%-31K
122.03%131K
-83.33%-110K
-1,789.66%-1.1M
728.13%1.06M
716.79%1.12M
Cash from discontinued investing activities
Operating cash flow
-217.24%-1.1M
32.73%-1.23M
85.98%-215K
-44.82%-6.15M
-74.98%-2.44M
-6.75%-348K
-40.34%-1.83M
-25.35%-1.53M
-25.75%-4.25M
5.49%-1.4M
Investing cash flow
Cash flow from continuing investing activities
-102.94%-1K
98.93%-2K
26.09%-17K
-160.61%-258K
-34.43%-82K
34K
-1,800.00%-187K
53.06%-23K
-125.52%-99K
-1,425.00%-61K
Net PPE purchase and sale
96.77%-1K
92.00%-2K
26.09%-17K
-96.35%-269K
-206.45%-190K
-3,000.00%-31K
0.00%-25K
53.06%-23K
23.46%-137K
-1,140.00%-62K
Net other investing changes
----
----
----
-71.05%11K
10,700.00%108K
6,400.00%65K
----
----
188.37%38K
100.16%1K
Cash from discontinued investing activities
Investing cash flow
-102.94%-1K
98.93%-2K
26.09%-17K
-160.61%-258K
-34.43%-82K
--34K
-1,800.00%-187K
53.06%-23K
-125.52%-99K
-1,425.00%-61K
Financing cash flow
Cash flow from continuing financing activities
514.47%1.32M
27.53%-129K
65.12%-135K
-66.35%2.49M
1,418.92%3.37M
-168.68%-318K
-102.57%-178K
-85.17%-387K
123.58%7.4M
-17.47%222K
Net issuance payments of debt
44.10%-128K
40.00%-129K
62.86%-130K
-1.34%-379K
86.94%415K
-15.08%-229K
-8.59%-215K
-75.88%-350K
-136.63%-374K
15.63%222K
Net common stock issuance
--1.45M
--0
---5K
-62.03%2.87M
--2.87M
--0
--0
--0
--7.55M
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-90.56%216K
--0
Net other financing activities
----
----
----
----
----
----
----
---37K
----
----
Cash from discontinued financing activities
Financing cash flow
514.47%1.32M
27.53%-129K
65.12%-135K
-66.35%2.49M
1,418.92%3.37M
-168.68%-318K
-102.57%-178K
-85.17%-387K
123.58%7.4M
-17.47%222K
Net cash flow
Beginning cash position
-36.23%2.14M
-36.56%3.54M
-48.35%3.82M
75.26%7.4M
-69.12%2.63M
-60.07%3.35M
98.72%5.59M
75.26%7.4M
14.33%4.22M
53.93%8.53M
Current changes in cash
133.70%213K
37.95%-1.36M
81.11%-367K
-228.60%-3.92M
168.80%849K
-561.31%-632K
-139.01%-2.2M
-31.20%-1.94M
858.81%3.05M
-1.90%-1.23M
Effect of exchange rate changes
165.88%56K
-12.50%-45K
-31.58%91K
171.65%345K
233.66%337K
---85K
13.04%-40K
84.72%133K
-39.81%127K
191.82%101K
End cash Position
-8.66%2.41M
-36.23%2.14M
-36.56%3.54M
-48.35%3.82M
-48.35%3.82M
-69.12%2.63M
-60.07%3.35M
98.72%5.59M
75.26%7.4M
75.26%7.4M
Free cash flow
-191.56%-1.11M
33.53%-1.23M
85.09%-232K
-46.43%-6.42M
-80.58%-2.63M
-15.90%-379K
-39.58%-1.86M
-22.33%-1.56M
-23.28%-4.39M
1.62%-1.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -217.24%-1.1M32.73%-1.23M85.98%-215K-44.82%-6.15M-74.98%-2.44M-6.75%-348K-40.34%-1.83M-25.35%-1.53M-25.61%-4.25M5.74%-1.4M
Net income from continuing operations 55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M-917.00%-1.02M19.22%-887K-28.76%-5.09M19.56%-2.94M
Operating gains losses ------------99.86%-1K----------------6.10%-723K--150K
Depreciation and amortization 40.63%45K60.71%45K45.16%45K-32.80%125K-30.61%34K-13.51%32K-46.15%28K-35.42%31K-18.06%186K22.50%49K
Deferred tax --------325.00%90K95.54%-37K--207K-----------40K---829K----
Other non cash items -------------22.42%173K----------------5,475.00%223K----
Change In working capital -132.99%-515K116.90%168K204.70%891K-159.53%-1.86M-148.23%-1.58M131.26%1.56M-69.05%-994K-266.81%-851K126.23%3.13M20.04%3.28M
-Change in receivables -306.23%-596K311.49%184K361.64%191K-96.85%62K-103.30%-67K-46.18%289K81.99%-87K34.82%-73K-24.42%1.97M-5.36%2.03M
-Change in inventory -274.04%-496K163.60%173K231.43%230K--0-39.10%162K166.90%285K-494.20%-272K-1,844.44%-175K-53.85%-100K-21.30%266K
-Change in prepaid assets 185.14%499K-72.30%131K-10.53%-84K33.48%-306K-52.96%-878K-55.92%175K785.51%473K64.49%-76K-9,100.00%-460K-240.69%-574K
-Change in payables and accrued expense -85.13%101K52.88%-499K-18.35%516K-138.66%-341K-189.71%-593K534.58%679K-2,202.17%-1.06M295.00%632K182.66%882K650.83%661K
-Change in other current assets -72.60%20K--0154.84%79K--------1.39%73K-211.11%-10K-53.73%31K--------
-Change in other current liabilities 71.83%-20K--015.96%-79K22.07%-173K-2.60%-79K0.00%-71K987.50%71K-42.42%-94K-3.26%-222K-160.16%-77K
-Change in other working capital -117.56%-23K262.73%179K103.47%38K-204.34%-1.11M-102.77%-31K122.03%131K-83.33%-110K-1,789.66%-1.1M728.13%1.06M716.79%1.12M
Cash from discontinued investing activities
Operating cash flow -217.24%-1.1M32.73%-1.23M85.98%-215K-44.82%-6.15M-74.98%-2.44M-6.75%-348K-40.34%-1.83M-25.35%-1.53M-25.75%-4.25M5.49%-1.4M
Investing cash flow
Cash flow from continuing investing activities -102.94%-1K98.93%-2K26.09%-17K-160.61%-258K-34.43%-82K34K-1,800.00%-187K53.06%-23K-125.52%-99K-1,425.00%-61K
Net PPE purchase and sale 96.77%-1K92.00%-2K26.09%-17K-96.35%-269K-206.45%-190K-3,000.00%-31K0.00%-25K53.06%-23K23.46%-137K-1,140.00%-62K
Net other investing changes -------------71.05%11K10,700.00%108K6,400.00%65K--------188.37%38K100.16%1K
Cash from discontinued investing activities
Investing cash flow -102.94%-1K98.93%-2K26.09%-17K-160.61%-258K-34.43%-82K--34K-1,800.00%-187K53.06%-23K-125.52%-99K-1,425.00%-61K
Financing cash flow
Cash flow from continuing financing activities 514.47%1.32M27.53%-129K65.12%-135K-66.35%2.49M1,418.92%3.37M-168.68%-318K-102.57%-178K-85.17%-387K123.58%7.4M-17.47%222K
Net issuance payments of debt 44.10%-128K40.00%-129K62.86%-130K-1.34%-379K86.94%415K-15.08%-229K-8.59%-215K-75.88%-350K-136.63%-374K15.63%222K
Net common stock issuance --1.45M--0---5K-62.03%2.87M--2.87M--0--0--0--7.55M--0
Proceeds from stock option exercised by employees --------------0-----------------90.56%216K--0
Net other financing activities -------------------------------37K--------
Cash from discontinued financing activities
Financing cash flow 514.47%1.32M27.53%-129K65.12%-135K-66.35%2.49M1,418.92%3.37M-168.68%-318K-102.57%-178K-85.17%-387K123.58%7.4M-17.47%222K
Net cash flow
Beginning cash position -36.23%2.14M-36.56%3.54M-48.35%3.82M75.26%7.4M-69.12%2.63M-60.07%3.35M98.72%5.59M75.26%7.4M14.33%4.22M53.93%8.53M
Current changes in cash 133.70%213K37.95%-1.36M81.11%-367K-228.60%-3.92M168.80%849K-561.31%-632K-139.01%-2.2M-31.20%-1.94M858.81%3.05M-1.90%-1.23M
Effect of exchange rate changes 165.88%56K-12.50%-45K-31.58%91K171.65%345K233.66%337K---85K13.04%-40K84.72%133K-39.81%127K191.82%101K
End cash Position -8.66%2.41M-36.23%2.14M-36.56%3.54M-48.35%3.82M-48.35%3.82M-69.12%2.63M-60.07%3.35M98.72%5.59M75.26%7.4M75.26%7.4M
Free cash flow -191.56%-1.11M33.53%-1.23M85.09%-232K-46.43%-6.42M-80.58%-2.63M-15.90%-379K-39.58%-1.86M-22.33%-1.56M-23.28%-4.39M1.62%-1.46M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg